As part of the Trump administration’s efforts aimed at stopping DEI, the government has been restricting how it monitors ...

Fatty acids and other food compounds may change disease activity among individuals with inflammatory bowel diseases.

Ustekinumab is more efficacious than vedolizumab or anti-TNFs as second- or third-line biologic therapy for perianal Crohn disease.

MASLD rates have decreased, whereas liver fibrosis and cirrhosis rates have increased among US patients with type 2 diabetes since 2017.

Higher UPF-consumption was linked to worse knee OA outcomes among women, including higher pain scores, worse physical function, and thinner knee cartilage.

The European Association for the Study of Obesity framework may offer a more sensitive measure of obesity than traditional body mass index.

Stratifying body mass index categories by waist circumference thresholds improves mortality risk prediction in postmenopausal women.

Among young people born in 2008 to 2017, 15.6 million lifetime gastric cancer cases are expected globally, with more than three-quarters attributable to Helicob ...

A government-backed meal delivery service for people on Medicaid and Medicare is getting national attention, but not all of it is positive.

Individuals with ulcerative colitis have an increased risk for certain types of cancer based on age, instead of treatment type.

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.